ELP1 and immunodeficiency disease: Here, we show that lowered fD levels decrease AP activation speed, which points towards a novel type of immunodeficiency that is characterised by an intact but too slow complement response, which predisposes to infections with rapidly proliferating bacteria that demand a rapidly accelerating response of complement.